Actress Samantha Ruth Prabhu opens up about her battle with Myositis and her decision to nearly leave the film industry to become a 'serial entrepreneur' before returning with the record-breaking hit 'Maa Inti Bangaram'.
- Samantha considered quitting acting due to health complications from Myositis.
- She pivoted toward business, describing herself as a 'serial entrepreneur' during her hiatus.
- 'Maa Inti Bangaram' became the highest-grossing female-led Telugu film, earning over Rs 100 crore.
- Director Raj Nidimoru played a pivotal role in convincing her to return to the screen.
In a candid revelation, Samantha Ruth Prabhu has detailed the harrowing period following her 2022 diagnosis of Myositis, an autoimmune disease that causes muscle inflammation. The physical and mental toll of the illness, coupled with a challenging experience on the set of Citadel: Honey Bunny, led the actress to the brink of retiring from cinema entirely.
Seeking a lifestyle that was less physically demanding, Samantha shifted her focus toward the corporate world. During her year-long break, she invested in various ventures, jokingly referring to herself as a "serial entrepreneur." She expressed a growing comfort with life behind the camera, preferring the role of a producer over the grueling demands of being a lead actor while her health remained fragile.
Why This Matters
BozokMedia analysis shows that Samantha's journey reflects a broader trend of high-profile celebrities prioritizing holistic wellness over professional momentum. Her transition from a state of vulnerability to leading a Rs 100-crore blockbuster demonstrates a significant shift in the commercial viability of female-led cinema in the Telugu industry, breaking the glass ceiling previously held by films like Arundhati.
The turning point came when Raj Nidimoru urged her to star in Maa Inti Bangaram. Interestingly, the role was originally envisioned for Sai Pallavi, who declined the project. Despite her initial reluctance and fears regarding her public reception after a three-year absence, Samantha agreed to the role, citing the strength of the script and the support of her collaborators.
"Women are extremely resilient, and keep getting back all the time. That resilience is what bridged the gap between the character and my own life experience."
The production of the film was a high-stakes gamble. With low pre-sale numbers and a tight budget, the team—including Himank and Raj—funded the project through personal savings and loans from friends and family. Samantha optimized production costs by shooting multiple sequences in a single day, ensuring the project's completion without reckless spending.
The result was a historic success. Maa Inti Bangaram not only surpassed the lifetime collections of Anushka Shetty’s 2009 classic Arundhati but also cemented Samantha's position as a powerhouse performer capable of carrying a film to massive commercial heights despite her health struggles.
| Metric | Arundhati (2009) | Maa Inti Bangaram (2026) |
|---|---|---|
| Lead Actress | Anushka Shetty | Samantha Ruth Prabhu |
| Box Office Status | Previous Record Holder | Current All-Time High |
| Revenue | High (Historic) | Rs 100+ Crore |
Frequently Asked Questions
Q1: What is Myositis and how did it affect Samantha?
Myositis is an inflammatory muscle disease. For Samantha, it led to physical collapses on set and severe mental exhaustion, making her consider quitting acting.
Q2: Who was the original choice for Maa Inti Bangaram?
The role was originally offered to actress Sai Pallavi before Raj Nidimoru convinced Samantha to take it.
